Event-Driven Stocks

ImageneBio, Inc.

IMANasdaq

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$800,000$3.5M$9.2M$15.6M$31.0M$9.2M
Operating income−$48.5M−$37.0M−$75.4M−$70.9M−$34.1M−$44.5M
Net income−$45.3M−$36.6M−$68.2M−$68.8M−$34.1M−$44.3M
Total assets$153.0M$15.9M$192.1M$172.3M$247.9M$168.4M
Total liabilities$19.8M$17.4M$22.3M$25.3M$40.0M$63.5M
Equity$133.1M−$160.6M−$126.1M$147.0M$207.9M−$101.0M
EPS (diluted)$-9.64$-22.10$-1.63$-1.90$-1.22—
Shares out.48.3M48.3M36.3M36.1M36.0M3.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−6056.4%
Net margin
−5668.6%
Return on equity
−34.1%
Return on assets
−29.6%
Return on capital (ROCE)
−34.2%
Liabilities / assets
13.0%
Debt / equity
0.15×
Book value / share
$2.76
Revenue growth (YoY)
−77.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
5.55safe
Accruals / assets
1.6%clean
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
40
/ 100
Profitability 0Growth 0Catalyst 67Earnings quality 33Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 4 warning● 3 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026445,0096.4-5.4%
Apr 30, 2026470,3397.6-19.9%
Apr 15, 2026587,2811.0+51.7%
Mar 31, 2026387,0349.1+2.4%
Mar 13, 2026378,15913.0-0.1%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.